Development of cancer in renal allograft recipients.
Yokota
K
K
Department of Surgery, J.R. Tokyo General Hospital, Japan.
Fukumitsu
M
M
Kuzuhara
K
K
Otsubo
O
O
Tomikawa
S
S
Nagao
T
T
Uchida
H
H
Sato
K
K
Nakayama
Y
Y
Endo
T
T
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D008875:Middle Aged; D009369:Neoplasms / Q000453:epidemiology* / Q000628:therapy; D013997:Time Factors
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents